These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39118363)

  • 21. Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery.
    Hansen AM; Rasmussen M; Svitek N; Harndahl M; Golde WT; Barlow J; Nene V; Buus S; Nielsen M
    Immunogenetics; 2014 Dec; 66(12):705-18. PubMed ID: 25186069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN; Flower DR
    Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors.
    Apostolopoulos V; Yu M; Corper AL; Li W; McKenzie IF; Teyton L; Wilson IA; Plebanski M
    J Mol Biol; 2002 May; 318(5):1307-16. PubMed ID: 12083519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Learning MHC I--peptide binding.
    Jojic N; Reyes-Gomez M; Heckerman D; Kadie C; Schueler-Furman O
    Bioinformatics; 2006 Jul; 22(14):e227-35. PubMed ID: 16873476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.
    Hoerter JA; Brzostek J; Artyomov MN; Abel SM; Casas J; Rybakin V; Ampudia J; Lotz C; Connolly JM; Chakraborty AK; Gould KG; Gascoigne NR
    J Exp Med; 2013 Aug; 210(9):1807-21. PubMed ID: 23940257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.
    Rasmussen M; Fenoy E; Harndahl M; Kristensen AB; Nielsen IK; Nielsen M; Buus S
    J Immunol; 2016 Aug; 197(4):1517-24. PubMed ID: 27402703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.
    Boehm KM; Bhinder B; Raja VJ; Dephoure N; Elemento O
    BMC Bioinformatics; 2019 Jan; 20(1):7. PubMed ID: 30611210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Learning a peptide-protein binding affinity predictor with kernel ridge regression.
    Giguère S; Marchand M; Laviolette F; Drouin A; Corbeil J
    BMC Bioinformatics; 2013 Mar; 14():82. PubMed ID: 23497081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.
    van der Burg SH; Visseren MJ; Brandt RM; Kast WM; Melief CJ
    J Immunol; 1996 May; 156(9):3308-14. PubMed ID: 8617954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mooring Stone-Like Arg
    Yue C; Xiang W; Huang X; Sun Y; Xiao J; Liu K; Sun Z; Qiao P; Li H; Gan J; Ba L; Chai Y; Qi J; Liu P; Qi P; Zhao Y; Li Y; Qiu HJ; Gao GF; Gao G; Liu WJ
    J Virol; 2022 Feb; 96(4):e0137821. PubMed ID: 34851145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform.
    Bruno PM; Timms RT; Abdelfattah NS; Leng Y; Lelis FJN; Wesemann DR; Yu XG; Elledge SJ
    Nat Biotechnol; 2023 Jul; 41(7):980-992. PubMed ID: 36593401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
    Bordner AJ
    PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting affinity and specificity of antigenic peptide binding to major histocompatibility class I molecules.
    Sieker F; May A; Zacharias M
    Curr Protein Pept Sci; 2009 Jun; 10(3):286-96. PubMed ID: 19519456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major Histocompatibility Complex Class I (FLA-E*01801) Molecular Structure in Domestic Cats Demonstrates Species-Specific Characteristics in Presenting Viral Antigen Peptides.
    Liang R; Sun Y; Liu Y; Wang J; Wu Y; Li Z; Ma L; Zhang N; Zhang L; Wei X; Qu Z; Zhang N; Xia C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of MHC class I binding peptides using profile motifs.
    Reche PA; Glutting JP; Reinherz EL
    Hum Immunol; 2002 Sep; 63(9):701-9. PubMed ID: 12175724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
    Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
    J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets.
    Shao XM; Bhattacharya R; Huang J; Sivakumar IKA; Tokheim C; Zheng L; Hirsch D; Kaminow B; Omdahl A; Bonsack M; Riemer AB; Velculescu VE; Anagnostou V; Pagel KA; Karchin R
    Cancer Immunol Res; 2020 Mar; 8(3):396-408. PubMed ID: 31871119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.